Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.830
+0.410 (28.87%)
At close: Mar 19, 2026, 4:00 PM EDT
1.830
0.00 (0.00%)
After-hours: Mar 19, 2026, 7:29 PM EDT
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $110.13 million as of March 19, 2026. Its market cap has decreased by -70.10% in one year.
Market Cap
110.13M
Enterprise Value
55.62M
1-Year Change
-70.10%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $110.13M, an increase of 196.06%. That is a compound annual growth rate of 9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 85.50M | -72.56% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
| May 2, 2014 | 37.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 119.02M |
| Sangamo Therapeutics | 114.74M |
| Inovio Pharmaceuticals | 114.00M |
| Genelux | 113.81M |
| Rani Therapeutics Holdings | 112.17M |
| Aardvark Therapeutics | 106.69M |
| Gossamer Bio | 106.08M |
| Oncolytics Biotech | 105.34M |